1461083321-48bf602c-c11f-4aed-9263-f80224728613

1. A method of mounting a hermetically sealed compressor having a housing, said method comprising:
providing a mounting member, said mounting member having a central support section, first and second legs extending from opposite ends of said support section, said first and second legs including first and second distal portions respectively extending from said first and second legs, each of said first and second distal portions respectively defining an angle with said first and second legs;
securing said mounting member to the housing wherein said support section is in registry with the housing;
providing an elongate bracing member having a first end and an opposite second end; and
securing said elongate bracing member to said mounting member to form a mounting bracket including fixedly engaging said bracing member proximate said first end with said first distal portion by deforming at least one of said bracing member and said first distal portion into engagement with the other of said bracing member and said first distal portion and fixedly engaging said bracing member proximate said second end with said second distal portion by deforming at least one of said bracing member and said second distal portion into engagement with the other of said bracing member and said second distal portion.
2. The method of claim 1 wherein said first and second distal portions each include a plurality of bent tabs extending therefrom and said step of securing said elongate bracing member to said mounting member further comprises positioning said first and second ends adjacent said bent tabs.
3. The method of claim 1 wherein said step of securing said mounting member to the housing precedes said step of securing said elongate bracing member to said mounting member.
4. The method of claim 1 further comprising:
providing a second mounting member, said second mounting member having a second central support section and third and fourth legs extending from opposite ends of said second support section, said third and fourth legs including third and fourth distal portions respectively extending from said third and fourth legs, each of said third and fourth distal portions respectively defining an angle with said third and fourth legs;
securing said second mounting member to said housing wherein said second support section is in registry with said housing;
providing a second elongate bracing member having a third end and an opposite fourth end; and
securing said second elongate bracing member to said second mounting member to form a second mounting bracket including fixedly engaging said second bracing member proximate said third end with said third distal portion by deforming at least one of said second bracing member and said third distal portion into engagement with the other of said second bracing member and said third distal portion and fixedly engaging said second bracing member proximate said fourth end with said fourth distal portion by deforming at least one of said second bracing member and said fourth distal portion into engagement with the other of said bracing member and said fourth distal portion.
5. The method of claim 4 wherein both said support section and said second support section comprise arcuate sections which each define a portion of a cylinder having a common axis.
6. The method of claim 5 wherein said mounting bracket and said second mounting bracket are secured to the housing in positions wherein said first, second, third and fourth legs are each disposed at a common angle to the common axis, said common angle being a non-perpendicular angle.
7. The method of claim 4 wherein said step of securing said mounting member to the housing and said step of securing said second mounting member to the housing both precede the steps of securing said elongate bracing member to said mounting member and securing said second elongate bracing member to said second mounting member.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A circuit comprising:
a high side transistor;
a low side transistor coupled in series with the high side transistor;
a pull down device coupled to a control node of the high side transistor and to a control node of the low side transistor; and
a Power On Reset circuit for monitoring a digital power supply and for controlling the pull down device such that the high side and low side transistors are OFF until the digital power supply has settled to a desired operating voltage.
2. The circuit of claim 1 wherein the pull down device comprises:
a first pull down transistor coupled to the control node of the high side transistor; and
a second pull down transistor coupled to the control node of the low side transistor.
3. The circuit of claim 2 wherein the pull down device further comprises a Power On Reset circuit controlled by the digital power supply for outputting a Power On Reset signal for controlling the first and second pull down transistors.
4. The circuit of claim 3 further comprising a transistor device coupled to a control node of the first pull down transistor and to a control node of the second pull down transistor, and having a control node coupled to the Power On Reset circuit.
5. The circuit of claim 4 further comprising a resistor coupled between the transistor device and a main power supply node.
6. The circuit of claim 1 further comprising a high side level shifter coupled to the control node of the high side transistor and powered by a main power supply node.
7. The circuit of claim 1 further comprising a low side level shifter coupled to the control node of the low side transistor and powered by a main power supply node.
8. The circuit of claim 6 further comprising a low side level shifter coupled to the control node of the low side transistor and powered by the main power supply node.
9. The circuit of claim 8 further comprising a digital logic circuit having an output coupled to an input of the high side level shifter and to an input of the low side level shifter, and powered by the digital power supply.
10. A circuit comprising:
a high side transistor coupled to a main power supply;
a low side transistor coupled in series with the high side transistor;
a high side level shifter having an output coupled to a control node of the high side transistor and powered by the main power supply;
a low side level shifter having an output coupled to a control node of the low side transistor and powered by the main power supply;
a pull down device coupled to the control node of the high side transistor and to the control node of the low side transistor;
a digital logic circuit having an output coupled to an input of the high side level shifter and to an input of the low side level shifter, and powered by a digital power supply; and
a Power On Reset circuit for monitoring the digital power supply and for controlling the pull down device such that the high side and low side transistors are OFF until the digital power supply has settled to a desired operating voltage.
11. The circuit of claim 10 wherein the pull down device comprises:
a first pull down transistor coupled to the control node of the high side transistor; and
a second pull down transistor coupled to the control node of the low side transistor.
12. The circuit of claim 11 further comprising a transistor device coupled to a control node of the first pull down transistor and to a control node of the second pull down transistor, and having a control node coupled to the Power On Reset circuit.
13. The circuit of claim 12 further comprising a resistor coupled between the transistor device and the main power supply.

1461083311-08590784-b8b6-4b14-b139-011d81d00b53

1. A sustained release oral dosage formulation of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, or a combination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3.
2. The sustained release oral dosage formulation of claim 1, wherein the formulation further provides delayed release of the 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, or combination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 after ingestion of the formulation.
3. The sustained release oral dosage formulation of claim 2, wherein release is substantially delayed until the 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, or combination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 reaches the ileum of the intestine.
4. The sustained release oral dosage formulation of claim 2, further comprising an enteric coating.
5. The sustained release oral dosage formulation of claim 1, comprising the 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, or combination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 dispersed within a matrix.
6. The sustained release oral dosage formulation of claim 5, wherein the matrix releasably binds the 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, or combination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3.
7. The sustained release oral dosage formulation of claim 6, wherein the matrix provides for release of the 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, or combination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 via diffusion.
8. The sustained release oral dosage formulation of claim 6, wherein the matrix provides for release of the 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, or combination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 via disintegration of the matrix.
9. The sustained release oral dosage formulation of claim 6, wherein the dosage form further comprises a permeable framework around the matrix.
10. The sustained release oral dosage formulation of claim 5, wherein the matrix comprises a wax matrix.
11. The sustained release oral dosage formulation of claim 10, wherein the wax matrix comprises a wax and an oil.
12. The sustained release oral dosage formulation of claim 5, further comprising a glyceride.
13. The sustained release oral dosage formulation of claim 5, further comprising a gelatin capsule, the wax matrix being disposed in the gelatin capsule.
14. The sustained release oral dosage formulation of claim 13, wherein the gelatin capsule is a hard gelatin capsule.
15. The sustained release oral dosage formulation of claim 5, wherein the formulation is semi-solid at body temperature.
16. The sustained release oral dosage formulation of claim 13, wherein the gelatin capsule is a soft gelatin capsule.
17. The sustained release oral dosage formulation of claim 1, wherein the 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, or a combination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 is contained in granules coated with a polymer.
18. The sustained release oral dosage formulation of claim 17, wherein the polymer comprises an insoluble polymer selected from the group consisting of methacrylic acid esters, polyvinyl esters, polyvinyl acetals, polyacrylic acid esters, and butadiene styrene copolymers.
19. The sustained release oral dosage formulation of claim 18, wherein the polymer comprises methacrylic acid esters.
20. The sustained release oral dosage formulation of claim 19, further comprising trimethylammonioethyl methacrylate chlorides.
21. The sustained release oral dosage formulation of claim 1, comprising 1 to 50 mcg per unit dose of the 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, or combination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3.
22. The sustained release oral dosage formulation of claim 1, wherein the sustained release is effected over a period of at least four hours.
23. The sustained release oral dosage formulation of claim 1, comprising 25-hydroxyvitamin D3.
24. The sustained release oral dosage formulation of claim 1, wherein the release of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, or a combination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 avoids supraphysiologic surges in intralumenal, intracellular, andor blood levels of 25-hydroxyvitamin D.
25. A sustained release oral dosage formulation of 25-hydroxyvitamin D3 dispersed within a wax matrix comprising a wax, an oil, and a glyceride, and disposed within a capsule.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A reinforced areal implant, comprising a net-type basic structure having a pore size in the mange of 1.5 mm to 4.0 mm and textile strengthening elements whose bending resistance, measured in a three-point flexibility test at a support length of 20 mm, is in the range of 0.015 Nmm to 0.4 Nmm, where the textile strengthening elements form a net-type strengthening structure with a pore size in the range of 5 mm to 30 mm, said pore size being a multiple of the pore size of the basic structure.
2. The implant according to claim 1, wherein the basic structure comprises knitware.
3. The implant according to claim 2, wherein the strengthening elements are laid or knitted into the basic structure.
4. The implant according to claim 1, wherein the basic structure comprises non-absorbable material or very slowly absorbable material that retains at least 50% of its initial tear-strength after 180 days in-vivo.
5. The implant according to claim 4, wherein the basic structure comprises multi-filament yarn made of polypropylene.
6. The implant according to claim 1, wherein the basic structure comprises absorbable multi-filament yarn.
7. The implant according to claim 1, wherein the basic structure has at least one component selected from the group consisting of yarn of poly-p-dioxanone, yarn of a copolymer of L-lactide and glycolide in the ratio of 10:90, yarn of a copolymer of L-lactide and glycolide in the ratio of 95:5, yarn of a copolymer of L-lactide and glycolide in a different ratio.
8. The implant according to claim 1, wherein the strengthening elements comprise at least one component selected from the group consisting of pure mono-filaments, twisted mono-filaments, twisted multi-filament yarns, and composite multi-filament yarns.
9. The implant according to claim 8, wherein the strengthening elements comprise at least one component selected from the group consisting of mono-filaments of polypropylene, multi-filament yarns of polypropylene, mono-filaments of poly-p-dioxanone, multi-filament yarns of a copolymer of L-lactide and glycolide in the ratio of 10:90, and yarns of poly-p-dioxanone.
10. The implant according to claim 1, wherein at least part of the strengthening elements has a color different from that of the basic structure.